PHRM 645 | Clinical Sciences: Renal
PHRM 680 | Clinical Sciences: Immunology
PHRM 703 | Advanced Pharmacy Practice Experiential Education
Academic, Research, & Practice: solid organ transplant, Legacy Transplant Services
2011 | Research Boot Camp, American Society of Health-Systems, Pharmacists Foundation, Bethesda, MD
2010 | Board Certified Pharmacotherapy Specialist, Board of Pharmacy Specialties
1994 | Pharmacy Practice Residency, Oregon Health & Science University, Portland, OR
1993 | Doctor of Pharmacy, University of the Pacific, Stockton, CA
1990 | Pre-pharmacy, University of Southern California, Los Angeles, CA
1989 | Pre-pharmacy, Indiana University, Bloomington, IN
2010 - | Legacy Transplant Services, Legacy Health, Good Samaritan Hospital, Portland, OR
Clinical Practice Site
2004-10 | Legacy Good Samaritan Hospital, Portland, OR
Inpatient Pharmacy Service, Transplantation, Internal Medicine, Anticoagulation
1999-04 | Salem Hospital, Salem, OR
Ambulatory Parenteral and Enteral Services, Anticoagulation
1996-99 | Children’s Home Care, San Diego, CA
Home Infusion Pharmacist
1994-96 | Children’s Hospital and Health Center, San Diego, CA
Inpatient--Surgical Clinical Pharmacist
Areas of Research & Specialization
Renal transplant pharmacotherapy
- Investigation of pharmacokinetics and pharmacodynamics monitoring of mycophenolate mofetil
- Evaluation of viral infection risk related to immunosuppression
- AUC Monitoring of Mycophenolate Mofetil
- Bioequivalence Comparison of Innovator and Generic Mycophenolate Mofetil in Renal Transplant Patients
- Fairytale Creative Writing to Improve Comprehension of Immunological Mechanism (comparison of student exam testing data with and without intervention)
- High Dose versus Low Dose Rabbit Anti-Thymocyte Globulin Induction Therapy in Kidney Transplantation
Pacific University Oregon School of Pharmacy
2013-16 | University Faculty Senate Representative
2014-15 | Assessment Committee
2013-14 | Faculty Search Committee
2012-13 | Chair, Curriculum Committee
2010 - | Faculty Advisor, Phi Delta Chi
Oregon Society of Health-System Pharmacists
2014 - | Legal & Regulatory Affairs Committee
2012-14 | OSHP-OSPA Joint Legislative Council (Appointed Representative)
2012-14 | Oregon delegate representative to ASHP
2012-13 | President
2010-11 | Chair, Annual Seminar Meeting
Publications and Poster Presentations (most recent 5 years)
Malhotra A, Kahlon P, Donoho T, Doyle IC. Pharmacogenomic considerations in the treatment of the pediatric cardiomyopathy called Barth Syndrome. Recent Patents on Biotechnology. Special issue: Current Topics in Pharmacogenomics. 2014, Accepted.
Doyle IC, Elbarbry FA. Area Under the Curve Comparison of Innovator vs. Generic Mycophenolate Mofetil (MMF) in Renal Transplant Recipients. Poster session presented at: World Transplant Congress; 2014 July 26-31; San Francisco, CA.
Karimi R, Doyle IC. Introduction to Immunology. In: Karimi, R. Biomedical and Pharmaceutical Sciences with Patient Care Correlations. 1st ed. Burlington (MA): Jones & Bartlett Learning; 2014. ISBN-13: 9781449621087
Doyle IC. Renal Pharmacotherapy delivery via “flipped classroom” model in a modified block curriculum. Poster session presented at: American Association of Colleges of Pharmacy Annual Meeting; 2013 July 14; Chicago, IL.
Doyle IC, Krupicka M, Vo T. Student Perceptions During the Implementation of the Flipped Classroom Model in a Modified Block Curriculum. Poster session presented at: American Association of Colleges of Pharmacy Annual Meeting; 2013 July 14; Chicago, IL.
Doyle IC, Cawley PA, Foeppel MP, Jordan JM, Krupicka M, Marcus KB, Meyer DA, Stamper BD, Vo T, Devaud L. Innovations in Education: Blending Modalities to Promote Student Learning. Poster session presented at: American Association of Colleges of Pharmacy Annual Meeting; 2013 July 13; Chicago, IL.
Sam T, Carlson E, Doyle I, Gabardi S, Hardinger K, Knorr J, McDevitt L, Ueda K, Tichy E. Risk of CMV after r-ATG or IL2 Antagonist Induction and the Impact of CMV-Directed Prophylaxis in Low Risk Renal Transplant Recipients. Platform presentation. American College of Clinical Pharmacy Annual Meeting; 2012 October 21-24; Hollywood, FL.
Sam T, Carlson E, Doyle I, Gabardi S, Hardinger K, Knorr J, McDevitt L, Ueda K, Tichy E. Impact of No Cytomegalovirus (CMV)-Directed Prophylaxis vs. CMV-Directed Prophylaxis on CMV Disease Incidence in Low-Risk Renal Transplant Recipients Receiving Rabbit Antithymocyte Globulin Induction. Poster session presented at: American Transplant Congress; 2012 June 2-6; Boston, MA.
Doyle IC, Fujisaki BS, Jordan JM. Fairytale Creative Writing to Improve Comprehension of Immunological Mechanisms. Poster session presented at: American Association of Colleges of Pharmacy Annual Meeting; 2011 July 10; San Antonio, TX.
Doyle IC, Zikri A, Bennett WM, Shaw LM, Figurski, MJ. Mycophenolate Mofetil Therapeutic Drug Monitoring: Combined Multi-linear Regression and Bayesian Limited Sampling Area Under the Curve versus Standard Care. Poster session presented at: Renal Week 2010. 43rd Annual Meeting & Scientific Exposition of the American Society of Nephrology; 2010 Nov 16-21; Denver, CO.
Doyle IC, Zikri A, Bennett WM, Shaw LM, Figurski, MJ. Area Under the Curve Bioequivalence of Mycophenolate Mofetil: CellCept® vs Generic. Poster session presented at: Renal Week 2010. 43rd Annual Meeting & Scientific Exposition of the American Society of Nephrology; 2010 Nov 16-21; Denver, CO.
AUC Monitoring of Mycophenolate Mofetil (May, 2009 - May, 2010) PGY1 Research Project Preceptor, Western States Conference – May, 2010.
Selected Invited Presentations
Dec 2011 | Bioequivalence Comparison of Mycophenolate Mofetil in Renal Transplant Patients, Pacific University College of Health Professions, Health & Sciences Seminar Series
Aug 2011 | Fairytale Creative Writing to Improve Comprehension of Immunological Mechanisms, Pacific University School of Pharmacy, Faculty Development Workshop
Apr 2009 | Immunosuppression: Management of Long Term Side Effects, Oregon Society of Health-System Pharmacists, Annual Seminar Meeting
Honors & Awards
Pacific University Oregon
2013 | Phi Lambda Sigma pharmacy fraternity, for outstanding leadership and service
2013 | Dean’s Faculty Excellence Award (Inaugural)
Oregon Society of Health-System Pharmacists
2012 | President’s Award for sustained contributions and leadership
2011 | Excellence in Education Award
2010 | President’s Award for Service